269 related articles for article (PubMed ID: 26962218)
1. Vaccination with Live Attenuated Simian Immunodeficiency Virus (SIV) Protects from Mucosal, but Not Necessarily Intravenous, Challenge with a Minimally Heterologous SIV.
Sutton MS; Burns CM; Weiler AM; Balgeman AJ; Braasch A; Lehrer-Brey G; Friedrich TC; O'Connor SL
J Virol; 2016 Jun; 90(12):5541-5548. PubMed ID: 26962218
[TBL] [Abstract][Full Text] [Related]
2. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses.
Abel K; Compton L; Rourke T; Montefiori D; Lu D; Rothaeusler K; Fritts L; Bost K; Miller CJ
J Virol; 2003 Mar; 77(5):3099-118. PubMed ID: 12584336
[TBL] [Abstract][Full Text] [Related]
3. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.
Burton SL; Kilgore KM; Smith SA; Reddy S; Hunter E; Robinson HL; Silvestri G; Amara RR; Derdeyn CA
Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10780-5. PubMed ID: 26261312
[TBL] [Abstract][Full Text] [Related]
4. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.
Stevceva L; Alvarez X; Lackner AA; Tryniszewska E; Kelsall B; Nacsa J; Tartaglia J; Strober W; Franchini G
J Virol; 2002 Nov; 76(22):11659-76. PubMed ID: 12388726
[TBL] [Abstract][Full Text] [Related]
5. Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm.
Nilsson C; Mäkitalo B; Thorstensson R; Norley S; Binninger-Schinzel D; Cranage M; Rud E; Biberfeld G; Putkonen P
AIDS; 1998 Dec; 12(17):2261-70. PubMed ID: 9863867
[TBL] [Abstract][Full Text] [Related]
6. A single vaccination with attenuated SIVmac 239 via the tonsillar route confers partial protection against challenge with SIVmac 251 at a distant mucosal site, the rectum.
Stahl-Hennig C; Eisenblatter M; Franz M; Stoiber H; Tenner-Racz K; Suh YS; Jasny E; Falkensammer B; Ugucchioni M; Georgsson G; Baroni C; Dierich MP; Lifson JD; Steinman RM; Uberla K; Racz P; Ignatius R
Front Biosci; 2007 Jan; 12():2107-23. PubMed ID: 17127448
[TBL] [Abstract][Full Text] [Related]
7. Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine.
Fuller DH; Rajakumar PA; Wilson LA; Trichel AM; Fuller JT; Shipley T; Wu MS; Weis K; Rinaldo CR; Haynes JR; Murphey-Corb M
J Virol; 2002 Apr; 76(7):3309-17. PubMed ID: 11884556
[TBL] [Abstract][Full Text] [Related]
8. Early potent protection against heterologous SIVsmE660 challenge following live attenuated SIV vaccination in Mauritian cynomolgus macaques.
Berry N; Ham C; Mee ET; Rose NJ; Mattiuzzo G; Jenkins A; Page M; Elsley W; Robinson M; Smith D; Ferguson D; Towers G; Almond N; Stebbings R
PLoS One; 2011; 6(8):e23092. PubMed ID: 21853072
[TBL] [Abstract][Full Text] [Related]
9. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
Connor RI; Montefiori DC; Binley JM; Moore JP; Bonhoeffer S; Gettie A; Fenamore EA; Sheridan KE; Ho DD; Dailey PJ; Marx PA
J Virol; 1998 Sep; 72(9):7501-9. PubMed ID: 9696847
[TBL] [Abstract][Full Text] [Related]
10. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
[TBL] [Abstract][Full Text] [Related]
11. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
Nixon DF; Donahoe SM; Kakimoto WM; Samuel RV; Metzner KJ; Gettie A; Hanke T; Marx PA; Connor RI
Virology; 2000 Jan; 266(1):203-10. PubMed ID: 10612675
[TBL] [Abstract][Full Text] [Related]
12. Vaccine protection against rectal acquisition of SIVmac239 in rhesus macaques.
Gonzalez-Nieto L; Castro IM; Bischof GF; Shin YC; Ricciardi MJ; Bailey VK; Dang CM; Pedreño-Lopez N; Magnani DM; Ejima K; Allison DB; Gil HM; Evans DT; Rakasz EG; Lifson JD; Desrosiers RC; Martins MA
PLoS Pathog; 2019 Sep; 15(9):e1008015. PubMed ID: 31568531
[TBL] [Abstract][Full Text] [Related]
13. Analysis of humoral immune responses in rhesus macaques vaccinated with attenuated SIVmac239Deltanef and challenged with pathogenic SIVmac251.
Freissmuth D; Hiltgartner A; Stahl-Hennig C; Fuchs D; Tenner-Racz K; Racz P; Uberla K; Strasak A; Dierich MP; Stoiber H; Falkensammer B
J Med Primatol; 2010 Apr; 39(2):97-111. PubMed ID: 20015159
[TBL] [Abstract][Full Text] [Related]
14. Protection of macaques with diverse MHC genotypes against a heterologous SIV by vaccination with a deglycosylated live-attenuated SIV.
Sugimoto C; Watanabe S; Naruse T; Kajiwara E; Shiino T; Umano N; Ueda K; Sato H; Ohgimoto S; Hirsch V; Villinger F; Ansari AA; Kimura A; Miyazawa M; Suzuki Y; Yamamoto N; Nagai Y; Mori K
PLoS One; 2010 Jul; 5(7):e11678. PubMed ID: 20652030
[TBL] [Abstract][Full Text] [Related]
15. A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease.
Amara RR; Patel K; Niedziela G; Nigam P; Sharma S; Staprans SI; Montefiori DC; Chenareddi L; Herndon JG; Robinson HL; McClure HM; Novembre FJ
J Virol; 2005 Dec; 79(24):15356-67. PubMed ID: 16306607
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine.
Sparger EE; Dubie RA; Shacklett BL; Cole KS; Chang WL; Luciw PA
Virology; 2008 May; 374(2):261-72. PubMed ID: 18261756
[TBL] [Abstract][Full Text] [Related]
17. Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques.
Carnathan DG; Wetzel KS; Yu J; Lee ST; Johnson BA; Paiardini M; Yan J; Morrow MP; Sardesai NY; Weiner DB; Ertl HC; Silvestri G
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):518-23. PubMed ID: 25550504
[TBL] [Abstract][Full Text] [Related]
18. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge.
Wyand MS; Manson K; Montefiori DC; Lifson JD; Johnson RP; Desrosiers RC
J Virol; 1999 Oct; 73(10):8356-63. PubMed ID: 10482586
[TBL] [Abstract][Full Text] [Related]
19. Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques.
Jensen K; Nabi R; Van Rompay KKA; Robichaux S; Lifson JD; Piatak M; Jacobs WR; Fennelly G; Canfield D; Mollan KR; Hudgens MG; Larsen MH; Amedee AM; Kozlowski PA; De Paris K
J Virol; 2016 Aug; 90(16):7285-7302. PubMed ID: 27252535
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.
Abel K; Rourke T; Lu D; Bost K; McChesney MB; Miller CJ
J Infect Dis; 2004 Nov; 190(9):1697-705. PubMed ID: 15478078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
